186 related articles for article (PubMed ID: 38253669)
1. A multicellular brain spheroid model for studying the mechanisms and bioeffects of ultrasound-enhanced drug penetration beyond the blood‒brain barrier.
Paranjape AN; D'Aiuto L; Zheng W; Chen X; Villanueva FS
Sci Rep; 2024 Jan; 14(1):1909. PubMed ID: 38253669
[TBL] [Abstract][Full Text] [Related]
2. Development of an In Vitro Model to Study Mechanisms of Ultrasound-Targeted Microbubble Cavitation-Mediated Blood-Brain Barrier Opening.
Conway GE; Paranjape AN; Chen X; Villanueva FS
Ultrasound Med Biol; 2024 Mar; 50(3):425-433. PubMed ID: 38158246
[TBL] [Abstract][Full Text] [Related]
3. Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines.
Kitamura K; Umehara K; Ito R; Yamaura Y; Komori T; Morio H; Akita H; Furihata T
Biol Pharm Bull; 2021 Jul; 44(7):984-991. PubMed ID: 33896887
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model.
Sokolova V; Nzou G; van der Meer SB; Ruks T; Heggen M; Loza K; Hagemann N; Murke F; Giebel B; Hermann DM; Atala AJ; Epple M
Acta Biomater; 2020 Jul; 111():349-362. PubMed ID: 32413579
[TBL] [Abstract][Full Text] [Related]
5. Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model.
Sokolova V; Mekky G; van der Meer SB; Seeds MC; Atala AJ; Epple M
Sci Rep; 2020 Oct; 10(1):18033. PubMed ID: 33093563
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
[TBL] [Abstract][Full Text] [Related]
7. Developing a transwell millifluidic device for studying blood-brain barrier endothelium.
Harding IC; O'Hare NR; Vigliotti M; Caraballo A; Lee CI; Millican K; Herman IM; Ebong EE
Lab Chip; 2022 Nov; 22(23):4603-4620. PubMed ID: 36326069
[TBL] [Abstract][Full Text] [Related]
8. The effect of ultrasound pulse length on microbubble cavitation induced antibody accumulation and distribution in a mouse model of breast cancer.
Amate M; Goldgewicht J; Sellamuthu B; Stagg J; Yu FTH
Nanotheranostics; 2020; 4(4):256-269. PubMed ID: 33033688
[TBL] [Abstract][Full Text] [Related]
9. Differential transcriptome response of blood brain barrier spheroids to neuroinvasive
Kulkarni A; Jozefiaková J; Bhide K; Mochnaćová E; Bhide M
Front Cell Infect Microbiol; 2023; 13():1326578. PubMed ID: 38179419
[TBL] [Abstract][Full Text] [Related]
10. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
[TBL] [Abstract][Full Text] [Related]
11. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
[TBL] [Abstract][Full Text] [Related]
12. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.
Wevers NR; Kasi DG; Gray T; Wilschut KJ; Smith B; van Vught R; Shimizu F; Sano Y; Kanda T; Marsh G; Trietsch SJ; Vulto P; Lanz HL; Obermeier B
Fluids Barriers CNS; 2018 Aug; 15(1):23. PubMed ID: 30165870
[TBL] [Abstract][Full Text] [Related]
13. Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.
Wang JD; Khafagy el-S; Khanafer K; Takayama S; ElSayed ME
Mol Pharm; 2016 Mar; 13(3):895-906. PubMed ID: 26751280
[TBL] [Abstract][Full Text] [Related]
14. A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood-Brain Barrier Transport Properties.
Eilenberger C; Rothbauer M; Selinger F; Gerhartl A; Jordan C; Harasek M; Schädl B; Grillari J; Weghuber J; Neuhaus W; Küpcü S; Ertl P
Adv Sci (Weinh); 2021 Jun; 8(11):e2004856. PubMed ID: 34105271
[TBL] [Abstract][Full Text] [Related]
15. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
16. A Novel Dynamic Human In Vitro Model for Studying the Blood-Brain Barrier.
Miranda-Azpiazu P; Saha S
Methods Mol Biol; 2022; 2492():157-173. PubMed ID: 35733044
[TBL] [Abstract][Full Text] [Related]
17. From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer.
Gonzales-Aloy E; Ahmed-Cox A; Tsoli M; Ziegler DS; Kavallaris M
Adv Drug Deliv Rev; 2023 May; 196():114777. PubMed ID: 36931346
[TBL] [Abstract][Full Text] [Related]
18. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.
Cai P; Zheng Y; Sun Y; Zhang C; Zhang Q; Liu Q
ACS Chem Neurosci; 2021 Oct; 12(20):3829-3837. PubMed ID: 34623131
[TBL] [Abstract][Full Text] [Related]
19. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system.
Smith BC; Tinkey RA; Shaw BC; Williams JL
Immunol Rev; 2022 Oct; 311(1):39-49. PubMed ID: 35909222
[TBL] [Abstract][Full Text] [Related]
20. Modeling the blood-brain barrier: Beyond the endothelial cells.
Gastfriend BD; Palecek SP; Shusta EV
Curr Opin Biomed Eng; 2018 Mar; 5():6-12. PubMed ID: 29915815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
